Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006 (2006), Article ID 31919, 4 pages
http://dx.doi.org/10.1155/MI/2006/31919
Research Communication

Flunisolide Decreases Exhaled Nitric Oxide and Nitrotyrosine Levels in Asthmatic Children

1Department of Paediatrics, University of Verona, Verona 37134, Italy
2Laboratory of Industrial Toxicology, Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma 43100, Italy

Received 10 April 2006; Revised 5 June 2006; Accepted 27 June 2006

Copyright © 2006 A. Bodini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I Rahman, D Morrison, K Donaldson, and W Macnee, “Systemic oxidative stress in asthma, COPD, and smokers,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4 I, pp. 1055–1060, 1996. View at Google Scholar
  2. T Hanazawa, S A Kharitonov, and P J Barnes, “Increased nitrotyrosine in exhaled breath condensate of patients with asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4 I, pp. 1273–1276, 2000. View at Google Scholar
  3. J S Beckman, T W Beckman, J Chen, P A Marshall, and B A Freeman, “Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1620–1624, 1990. View at Publisher · View at Google Scholar
  4. S Matalon, P Hu, H Ischiropoulos, and J S Beckman, “Peroxynitrite inhibition of oxygen consumption and ion transport in alveolar type II pneumocytes,” Chest, vol. 105, no. 3 suppl, p. 74S, 1994. View at Google Scholar
  5. G Sadeghi-Hashjin, G Folkerts, P AJ Henricks et al., “Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 5, pp. 1697–1701, 1996. View at Google Scholar
  6. P Montuschi, M Corradi, G Ciabattoni, J Nightingale, S A Kharitonov, and P J Barnes, “Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 216–220, 1999. View at Google Scholar
  7. P J Barnes and S A Kharitonov, “Exhaled nitric oxide: a new lung function test,” Thorax, vol. 51, no. 3, pp. 233–237, 1996. View at Google Scholar
  8. J Mattes, K Storm Van's Gravesande, U Reining et al., “NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma,” European Respiratory Journal, vol. 13, no. 6, pp. 1391–1395, 1999. View at Publisher · View at Google Scholar
  9. D Saleh, P Ernst, S Lim, P J Barnes, and A Giaid, “Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid,” FASEB Journal, vol. 12, no. 11, pp. 929–937, 1998. View at Google Scholar
  10. E Baraldi, S Carraro, R Alinovi et al., “Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations,” Thorax, vol. 58, no. 6, pp. 505–509, 2003. View at Publisher · View at Google Scholar
  11. “American Thoracic Society Committee on Diagnostic Standards for Nontubercolosis Respiratory Diseases. Definitions and classifications of chronic bronchitis, asthma and pulmonary emphysema,” American Review of Respiratory Disease, vol. 85, pp. 762–768, 1962.
  12. “American Thoracic Society. Standardization of spirometry: 1994 update,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 3, pp. 1107–1136, 1995.
  13. E Baraldi and J de Jongste, “European Respiratory Society / American Thoracic Society. Measurement of exhaled nitric oxide in children, 2001,” European Respiratory Journal, vol. 20, no. 1, pp. 223–237, 2002. View at Publisher · View at Google Scholar
  14. J Bousquet, P K Jeffery, W W Busse, M Johnson, and A M Vignola, “Asthma from bronchoconstriction to airway inflammation and remodelling,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1720–1745, 2000. View at Google Scholar
  15. S A Kharitonov, D H Yates, R A Robbins, R Logan-Sinclair, E A Shinebourne, and P J Barnes, “Increased nitric oxide in exhaled air of asthmatic patients,” Lancet, vol. 15, no. 343, pp. 133–135, 1994. View at Publisher · View at Google Scholar
  16. A Jatakanon, S Kharitonov, S Lim, and P J Barnes, “Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma,” Thorax, vol. 54, no. 2, pp. 108–114, 1999. View at Google Scholar
  17. P G Gibson, R L Henry, and P Thomas, “Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate,” European Respiratory Journal, vol. 16, no. 5, pp. 1008–1015, 2000. View at Google Scholar
  18. B Balint, S A Kharitonov, T Hanazawa et al., “Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis,” European Respiratory Journal, vol. 17, no. 6, pp. 1201–1207, 2001. View at Publisher · View at Google Scholar
  19. D A Kaminsky, J Mitchell, N Carroll, A James, R Soultanakis, and Y Janssen, “Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma,” Journal of Allergy and Clinical Immunology, vol. 104, no. 4 I, pp. 747–754, 1999. View at Publisher · View at Google Scholar
  20. E Baraldi, G Giordano, M F Pasquale et al., “3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 61, no. 1, pp. 90–96, 2006. View at Publisher · View at Google Scholar · View at PubMed
  21. C Bergeron, H P Hauber, M Gotfried et al., “Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide,” Journal of Allergy and Clinical Immunology, vol. 116, no. 5, pp. 983–989, 2005. View at Publisher · View at Google Scholar · View at PubMed